CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Unrealized Gain (Loss) on Derivatives	$ 0	$ 104
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	(101,139)	(150,051)
Adjustments to reconcile net loss to net cash generated from / (used in) continuing operating activities:
Loss from discontinued operations, net of tax (Note 3)	18,388	896
Amortization of program rights	177,586	180,803
Depreciation and other amortization	40,639	32,513
Loss on extinguishment of debt (Note 5)	(24,161)	(23,115)
Loss / (gain) on disposal of fixed assets	(1,069)	26
Stock-based compensation (Note 17)	581	2,180
Foreign currency exchange (gain) / loss, net	(2,467)	34,805
Net change in (net of effects of disposals of businesses):
Accounts receivable, net	(17,237)	11,549
Accounts payable and accrued liabilities	187	2,329
Program rights	(176,446)	(167,421)
Other assets	1,934	(511)
Accrued interest	(3,136)	(9,188)
Income taxes payable	(61)	(3,653)
Deferred revenue	14,799	15,726
Deferred taxes	12	(11,177)
VAT and other taxes payable	4,214	965
Net cash used in continuing operating activities	(16,916)	(37,250)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(14,199)	(14,808)
Disposal of property, plant and equipment	145	264
Net cash used in continuing investing activities	(14,054)	(14,544)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of Senior Debt	221,374	0
Repayments of Senior Debt	(400,673)	(310,322)
Debt transactions costs	(12,592)	(785)
Change in restricted cash	0	20,467
Proceeds from credit facilities	16,801	377
Payment of credit facilities and capital leases	(749)	(876)
Issuance of common stock	0	157,116
Issuance of common stock warrants	191,825	0
Issuance of preferred stock	0	200,000
Equity issuance costs	0	(4,322)
Dividends paid to holders of noncontrolling interests	(46)	(184)
Net cash provided by continuing financing activities	15,940	61,471
Net cash used in discontinued operations - operating activities	(645)	(1,053)
Net cash (used in) / provided by discontinued operations - financing activities	(107)	67
Impact of exchange rate fluctuations on cash and cash equivalents	(18)	(3,477)
Net (decrease) / increase in cash and cash equivalents	(15,800)	5,214
CASH AND CASH EQUIVALENTS, beginning of period	103,624	138,679
CASH AND CASH EQUIVALENTS, end of period	87,824	143,893
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES
Accretion on Series B Convertible Redeemable Preferred Stock	7,803	247
Interest paid in-kind	$ 727	$ 0